Verfahren zum Analysieren von Blutkomponenten und Blutkomponentenanalysevorrichtung

EP2888998 Art A3 16. September 2015

Anmelder: Seiko Epson Corporation 🇯🇵

Details

Veröffentlichungs-Nr.
EP2888998
Aktenzeichen
EP14200289
Anmeldetag
24. Dezember 2014
Veröffentlichung
16. September 2015
Rechtsraum
EP
IPC
A61B5/1455
Offizieller Volltext

Abstract

A blood component is accurately analyzed by appropriately extracting a blood-vessel (7) transmitted light component. In a blood component analyzing apparatus, a sensor section (50) has a light-emitting section (52) that irradiates light from a predetermined irradiation position situated over a blood vessel and a light-receiving section (54) including a first photodetector that receives light at a first light-receiving position that is different from the irradiation position and is situated over the blood vessel and a second photodetector that receives light at a second light-receiving position that is not situated over the blood vessel. A spectrum synthesizing section (156) synthesizes a first light-reception result at the first light-receiving position and a second light-reception result at the second light-receiving position by performing a predetermined synthesis process based on a positional relationship among the irradiation position, first light-receiving position, and second light-receiving position. A blood component analyzing section (157) analyzes a blood component using the synthesis result.

Anmelder

Firma
Seiko Epson Corporation
Land
🇯🇵 Japan
🇯🇵 Epson

Japanisches Unternehmen, das Drucker, Scanner, Projektoren sowie Uhrwerke und Sensortechnik entwickelt und herstellt.

7.318 Patente in unserer Datenbank

Vertreten von

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen